Who
Daniel Calkins
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Verastem.
In numbers
- Trades disclosed
- 59
- Buys
- 0
- Sells
- 36
- Bought
- $0
- Sold
- $248K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Dec 2022
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $21K2,566 at $8.00 | filing |
| 30 Sep 2026filed 2 Oct 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $42455 at $7.70 | filing |
| 21 Sep 2026filed 23 Sep 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $42455 at $7.70 | filing |
| 22 Jun 2026filed 24 Jun 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $17K4,032 at $4.18 | filing |
| 22 Jun 2026filed 24 Jun 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $23557 at $4.13 | filing |
| 22 Jun 2026filed 24 Jun 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $17K4,032 at $4.18 | filing |
| 22 Jun 2026filed 24 Jun 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $23557 at $4.13 | filing |
| 20 Mar 2026filed 23 Mar 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | $32757 at $5.74 | filing |
| 20 Mar 2026filed 23 Mar 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | $32757 at $5.74 | filing |
| 21 Jan 2026filed 23 Jan 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —16,665 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —16,665 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $36K5,039 at $7.16 | filing |
| 12 Jan 2026filed 14 Jan 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $36K5,039 at $7.16 | filing |
| 24 Dec 2025filed 29 Dec 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $62980 at $7.86 | filing |
| 24 Sep 2025filed 24 Sep 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $23125 at $9.23 | filing |
| 22 Sep 2025filed 24 Sep 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $51857 at $9.08 | filing |
| 23 Jun 2025filed 24 Jun 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $11825 at $4.71 | filing |
| 20 Jun 2025filed 24 Jun 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $21K4,110 at $5.13 | filing |
| 20 May 2025filed 20 May 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $91K11,143 at $8.13 | filing |
News
Verastem (NASDAQ:VSTM) Stock Price Target Raised at MizuhoVSTM · tickerreport.com · 16 Oct 2026Verastem (NASDAQ:VSTM) Shares Gap Up – Time to Buy?VSTM · tickerreport.com · 14 Oct 2026Verastem (NASDAQ:VSTM) Stock Falls 7% – Here's What HappenedVSTM · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Daniel Calkins; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.